RESMED INC
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Oct 29, 2026 (3 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 15, 2026 | RBC Capital | upgrade | Sector Perform → Outperform | — | 55% |
| Aug 31, 2026 | Keybanc | maintain | Overweight → Overweight | — | 52% |
| Aug 19, 2026 | Rothschild & Co | initiate | — → Neutral | — | 56% |
| Aug 7, 2026 | RBC Capital | maintain | Sector Perform → Sector Perform | — | 55% |
| Aug 7, 2026 | Piper Sandler | maintain | Neutral → Neutral | — | 54% |
| Aug 7, 2026 | Keybanc | maintain | Overweight → Overweight | — | 52% |
| Aug 7, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jul 15, 2026 | Mizuho | maintain | Outperform → Outperform | — | 52% |
| Jul 13, 2026 | Citigroup | downgrade | Buy → Neutral | — | 54% |
| Jul 10, 2026 | Jefferies | maintain | Hold → Hold | — | 52% |
| Jul 8, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jul 8, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jun 22, 2026 | Keybanc | maintain | Overweight → Overweight | — | 52% |
| Jun 17, 2026 | Morgan Stanley | downgrade | Overweight → Equal-Weight | — | 54% |
| Jun 15, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| May 1, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| May 1, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Apr 27, 2026 | Keybanc | maintain | Overweight → Overweight | — | 52% |
| Apr 9, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Feb 2, 2026 | Citigroup | maintain | Buy → Buy | $345 | 54% |
| Jan 30, 2026 | RBC Capital | maintain | Outperform → Outperform | $314 | 55% |
| Jan 30, 2026 | Piper Sandler | maintain | Neutral → Neutral | $275 | 54% |
| Jan 30, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $270 | 54% |
| Jan 30, 2026 | Stifel | maintain | Hold → Hold | $265 | 53% |
| Dec 18, 2025 | Stifel | maintain | Hold → Hold | $260 | 53% |
| Dec 16, 2025 | Baird | downgrade | Outperform → Neutral | $275 | 55% |
| Nov 3, 2025 | Baird | maintain | Outperform → Outperform | $300 | 55% |
| Oct 31, 2025 | RBC Capital | maintain | Outperform → Outperform | $303 | 55% |
| Oct 31, 2025 | Keybanc | maintain | Overweight → Overweight | $299 | 52% |
| Oct 31, 2025 | Mizuho | maintain | Outperform → Outperform | $300 | 52% |
| Oct 21, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $304 | 54% |
| Oct 13, 2025 | Wells Fargo | initiate | — → Equal-Weight | $280 | 54% |
| Sep 18, 2025 | Citigroup | initiate | — → Buy | $330 | 54% |
| Aug 1, 2025 | Mizuho | maintain | Outperform → Outperform | $290 | 52% |
| Aug 1, 2025 | Stifel | maintain | Hold → Hold | $270 | 53% |
| Aug 1, 2025 | RBC Capital | maintain | Outperform → Outperform | $300 | 55% |
| Aug 1, 2025 | UBS | maintain | Buy → Buy | $325 | 54% |
| Aug 1, 2025 | Keybanc | maintain | Overweight → Overweight | $298 | 52% |
| Aug 1, 2025 | Piper Sandler | maintain | Neutral → Neutral | $270 | 54% |
| Jul 16, 2025 | RBC Capital | upgrade | Sector Perform → Outperform | $294 | 55% |
| Jul 16, 2025 | Mizuho | maintain | Outperform → Outperform | $270 | 52% |
| Apr 24, 2025 | RBC Capital | maintain | Sector Perform → Sector Perform | $255 | 55% |
| Apr 24, 2025 | UBS | maintain | Buy → Buy | $285 | 54% |
| Apr 24, 2025 | JP Morgan | maintain | Overweight → Overweight | $290 | 55% |
| Apr 24, 2025 | Piper Sandler | maintain | Neutral → Neutral | $248 | 54% |
| Apr 24, 2025 | Keybanc | maintain | Overweight → Overweight | $274 | 52% |
| Apr 21, 2025 | Keybanc | maintain | Overweight → Overweight | $269 | 52% |
| Mar 5, 2025 | Citigroup | upgrade | Neutral → Buy | $0 | 54% |
| Mar 5, 2025 | Stifel | maintain | Hold → Hold | $240 | 53% |
| Jan 31, 2025 | JP Morgan | maintain | Overweight → Overweight | $286 | 55% |
No cross-platform signals in the last 90 days